CClinicalTrials.gg
CompletedNCT04352192Updated Sep 5, 2021

Effect of Kinesiotaping on Muscle Activity

An interventional study of Kinesiotaping in Healthy, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-05.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The aim of the investigator's study is to analyze the effect of kinesiotaping (KT) on the electrical activity of the muscle by using time and frequency domain analysis of the electromyography (EMG) signals.

Read the detailed description

The kinesiotaping (KT) is a taping technique that is commonly used to improve muscle performance and facilitate or inhibit muscle activity in rehabilitation. A study reported that KT application did not change electrical activity in the early period (immediately after KT, 5th and 10 minutes after KT). However, another study showed that EMG activity increased 24 hours after KT application. A study revealed that the KT produced more EMG activity compare to placebo taping. In conclusion, the effect of KT on electrical muscular activity was arguable in the literature.

02

Conditions studied

  • Healthy

Keywords

  • kinesiotaping
  • EMG
03

In context

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 345 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • To be right-handed-dominant
  • To have normal or corrected vision
  • To have no formal history of any resistance training.

Exclusion criteria

Exclusion Criteria:

  • To have history of neurological or recent musculoskeletal injury
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Kinesiotaping Group

    The group in which kinesiotaping is going to be applied to biceps brachii muscle of participants and will assess EMG activities before KT, immediately after KT, after 30 minutes and 24 hours of KT. The EMG analysis will be performed during maximum isometric voluntary contraction of biceps brachii muscle.

    Other: Kinesiotaping

  • No intervention
    Control Group

    The group in which kinesiotaping is not going to be applied. EMG activities will be assessed first assessment and after 10th minutes, 30th minutes and 24th hours of the first assessment. The EMG analysis will be performed during maximum isometric voluntary contraction of biceps brachii muscle.

Interventions

  • OtherKinesiotaping

    For kinesiotaping, the elbow positioned in 30°-45° flexion and kinesiotaping facilitation technique is applied origin to insertion of biceps brachii muscle.

06

What researchers measure

Primary outcomes

  1. The first assessment of electromyographic activity

    The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device before KT for KT group or as a first assessment of the control group. The test will be repeated three times.

    Time frame: at inclusion

  2. The second assessment of electromyographic activity

    The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device immediately after KT application for KT group or at 10th minutes after the first assessment as a second assessment of the control group. The test will be repeated three times.

    Time frame: after KT application for KT group or at 10th minutes after the first assessment

  3. The third assessment of electromyographic activity

    The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device at 30 minutes after the second assessment. The test will be repeated three times.

    Time frame: 30 minutes after the second assessment

  4. The last assessment of electromyographic activity

    The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device at 24 hours after KT application or the second assessment. The test will be repeated three times.

    Time frame: at 24 hours after KT application or the second assessment

Secondary outcomes

  1. The first assessment of maximum isometric voluntary contraction torque

    The produced elbow flexion torque during first EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.

    Time frame: at inclusion

  2. The second assessment of maximum isometric voluntary contraction torque

    The produced elbow flexion torque during second EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.

    Time frame: after KT application for KT group or at 10th minutes after the first assessment

  3. The third assessment of maximum isometric voluntary contraction torque

    The produced elbow flexion torque during third EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.

    Time frame: 30 minutes after the second assessment

  4. The last assessment of maximum isometric voluntary contraction torque

    The produced elbow flexion torque during the last EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.

    Time frame: at 24 hours after KT application or the second assessment

07

Study locations

1 site
  • Bezmialem Vakıf University
    Istanbul, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 5, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04352192
Lead sponsor
Bezmialem Vakif University
Collaborators
Istanbul University - Cerrahpasa
Responsible party
Hilal Denizoğlu Külli (Assistant professor, Bezmialem Vakif University) — Principal investigator
First posted
Apr 20, 2020
Start date
Aug 12, 2020
Primary completion
Aug 12, 2020
Completion
Aug 13, 2021
Last update
Sep 5, 2021

Study contacts

Hilal DENIZOGLU KULLI, PhD
study director · Bezmialem Vakif University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion